Rosen Law Firm Reminds Nymox Pharmaceutical Corporation Investors of Important January 26, 2015 Class Action Deadline -- NYMX...
January 12 2015 - 03:09PM
The Rosen Law Firm reminds purchasers of Nymox Pharmaceutical
Corporation common stock (Nasdaq:NYMX) during the period from
January 31, 2011 through November 2, 2014, of the important January
26, 2015 lead plaintiff deadline in the class action.
To join the Nymox class action, go to the website
http://www.rosenlegal.com/cases-447.html or call Phillip Kim, Esq.
or Kevin Chan, Esq. toll-free at 866-767-3653 or email
pkim@rosenlegal.com or kchan@rosenlegal.com for information on the
class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY CHOOSE TO DO NOTHING AT THIS POINT AND REMAIN
AN ABSENT CLASS MEMBER.
The lawsuit asserts that Nymox failed to disclose material
information affecting its Phase 3 clinical trials for Nymox's
proprietary drug NX-1207 for the treatment of benign prostatic
hyperplasia (BPH). Specifically, the Complaint alleges that Nymox
misled investors by misrepresenting or concealing: (1) that the
Phase 3 trial results were not objective; (2) the difficulty in
obtaining objective and measured results; (3) the small likelihood
of enrolling sufficient patients for the trial; and (4) the trial
had an unreasonably small chance of success.
On November 2, 2014, Nymox disclosed that its two Phase 3
studies of NX-1207 were halted because the drug failed to meets its
primary endpoints for efficacy. On November 3, 2014, Nymox held an
investor conference call in which it admitted it was aware of
certain problems concerning the Phase 3 trials. As a result of this
adverse information, Nymox's share price dropped over $4.0/share or
more than 80%, damaging investors.
If you wish to join the class action at no cost go to
http://www.rosenlegal.com/cases-447.html or to discuss your rights
or interests regarding this class action, please contact, Phillip
Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at
866-767-3653 or via e-mail at pkim@rosenlegal.com or
kchan@rosenlegal.com.
CONTACT: Laurence Rosen, Esq.
Phillip Kim, Esq.
Jonathan Horne, Esq.
The Rosen Law Firm P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
jhorne@rosenlegal.com
www.rosenlegal.com
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Mar 2023 to Mar 2024